Bio-Rad Laboratories Return on Tangible Equity 2012-2025 | BIO
Current and historical return on tangible equity values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Bio-Rad Laboratories Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.68B | $5.77B | -11.38% |
| 2025-06-30 | $0.32B | $6.15B | 5.16% |
| 2025-03-31 | $-2.17B | $5.97B | -35.12% |
| 2024-12-31 | $-1.85B | $5.87B | -27.32% |
| 2024-09-30 | $-0.78B | $6.77B | -10.69% |
| 2024-06-30 | $-1.33B | $6.06B | -17.63% |
| 2024-03-31 | $-0.32B | $8.33B | -4.06% |
| 2023-12-31 | $-0.64B | $8.01B | -7.86% |
| 2023-09-30 | $-0.16B | $7.70B | -1.91% |
| 2023-06-30 | $-0.43B | $7.71B | -5.13% |
| 2023-03-31 | $-0.19B | $9.03B | -2.25% |
| 2022-12-31 | $-3.63B | $8.88B | -42.01% |
| 2022-09-30 | $-6.02B | $7.73B | -62.16% |
| 2022-06-30 | $-1.93B | $8.34B | -16.82% |
| 2022-03-31 | $-0.09B | $9.59B | -0.74% |
| 2021-12-31 | $4.25B | $13.08B | 34.59% |
| 2021-09-30 | $6.67B | $14.86B | 58.61% |
| 2021-06-30 | $4.05B | $11.12B | 41.61% |
| 2021-03-31 | $4.11B | $10.13B | 47.33% |
| 2020-12-31 | $3.81B | $9.39B | 50.09% |
| 2020-09-30 | $3.52B | $8.33B | 53.30% |
| 2020-06-30 | $1.95B | $6.85B | 34.13% |
| 2020-03-31 | $1.58B | $5.89B | 29.96% |
| 2019-12-31 | $1.76B | $5.35B | 35.73% |
| 2019-09-30 | $0.38B | $4.72B | 8.35% |
| 2019-06-30 | $0.90B | $5.12B | 20.62% |
| 2019-03-31 | $0.57B | $4.49B | 13.98% |
| 2018-12-31 | $0.37B | $3.67B | 9.30% |
| 2018-09-30 | $1.28B | $4.25B | 35.75% |
| 2018-06-30 | $1.03B | $3.98B | 33.80% |
| 2018-03-31 | $0.77B | $3.81B | 29.78% |
| 2017-12-31 | $0.12B | $2.25B | 5.75% |
| 2017-09-30 | $0.02B | $2.15B | 0.78% |
| 2017-06-30 | $0.01B | $2.10B | 0.60% |
| 2017-03-31 | $0.03B | $2.00B | 1.28% |
| 2016-12-31 | $0.03B | $1.94B | 1.32% |
| 2016-09-30 | $0.09B | $1.98B | 5.06% |
| 2016-06-30 | $0.09B | $1.88B | 5.20% |
| 2016-03-31 | $0.10B | $1.79B | 5.99% |
| 2015-12-31 | $0.11B | $1.78B | 6.67% |
| 2015-09-30 | $0.10B | $1.70B | 6.59% |
| 2015-06-30 | $0.10B | $1.61B | 6.60% |
| 2015-03-31 | $0.10B | $1.45B | 7.10% |
| 2014-12-31 | $0.09B | $1.43B | 6.32% |
| 2014-09-30 | $0.08B | $1.39B | 5.71% |
| 2014-06-30 | $0.06B | $1.42B | 4.42% |
| 2014-03-31 | $0.07B | $1.46B | 4.74% |
| 2013-12-31 | $0.08B | $1.40B | 5.92% |
| 2013-09-30 | $0.09B | $1.33B | 7.10% |
| 2013-06-30 | $0.14B | $1.29B | 11.35% |
| 2013-03-31 | $0.15B | $1.24B | 12.77% |
| 2012-12-31 | $0.17B | $1.26B | 14.09% |
| 2012-09-30 | $0.18B | $1.18B | 16.40% |
| 2012-06-30 | $0.19B | $1.15B | 16.80% |
| 2012-03-31 | $0.18B | $1.10B | 16.12% |
| 2011-12-31 | $0.18B | $1.02B | 16.52% |
| 2011-09-30 | $0.19B | $1.14B | 17.43% |
| 2011-06-30 | $0.19B | $1.13B | 18.51% |
| 2011-03-31 | $0.18B | $1.05B | 20.10% |
| 2010-12-31 | $0.19B | $0.97B | 22.09% |
| 2010-09-30 | $0.16B | $0.87B | 19.86% |
| 2010-06-30 | $0.15B | $0.77B | 20.30% |
| 2010-03-31 | $0.15B | $0.75B | 21.61% |
| 2009-12-31 | $0.15B | $0.75B | 22.62% |
| 2009-09-30 | $0.10B | $0.68B | 16.94% |
| 2009-06-30 | $0.09B | $0.60B | 16.15% |
| 2009-03-31 | $0.09B | $0.54B | 17.47% |
| 2008-12-31 | $0.09B | $0.52B | 17.06% |
| 2008-09-30 | $0.11B | $0.53B | 21.80% |
| 2008-06-30 | $0.11B | $0.55B | 19.32% |
| 2008-03-31 | $0.09B | $0.50B | 15.06% |
| 2007-12-31 | $0.09B | $0.43B | 14.07% |
| 2007-09-30 | $0.10B | $0.78B | 13.68% |
| 2007-06-30 | $0.09B | $0.73B | 13.63% |
| 2007-03-31 | $0.10B | $0.70B | 15.14% |
| 2006-12-31 | $0.10B | $0.66B | 16.61% |
| 2006-09-30 | $0.10B | $0.65B | 16.91% |
| 2006-06-30 | $0.09B | $0.62B | 16.88% |
| 2006-03-31 | $0.08B | $0.56B | 15.41% |
| 2005-12-31 | $0.08B | $0.52B | 16.68% |
| 2005-09-30 | $0.08B | $0.49B | 18.39% |
| 2005-06-30 | $0.07B | $0.46B | 17.19% |
| 2005-03-31 | $0.08B | $0.46B | 18.60% |
| 2004-12-31 | $0.07B | $0.43B | 16.09% |
| 2004-09-30 | $0.07B | $0.38B | 16.68% |
| 2004-06-30 | $0.07B | $0.44B | 17.53% |
| 2004-03-31 | $0.07B | $0.45B | 17.68% |
| 2003-12-31 | $0.08B | $0.41B | 19.91% |
| 2003-09-30 | $0.07B | $0.39B | 20.46% |
| 2003-06-30 | $0.08B | $0.38B | 24.26% |
| 2003-03-31 | $0.08B | $0.34B | 24.90% |
| 2002-12-31 | $0.07B | $0.31B | 24.95% |
| 2002-09-30 | $0.07B | $0.28B | 28.11% |
| 2002-06-30 | $0.06B | $0.27B | 26.58% |
| 2002-03-31 | $0.06B | $0.23B | 27.67% |
| 2001-12-31 | $0.05B | $0.21B | 24.83% |
| 2001-09-30 | $0.04B | $0.19B | 21.99% |
| 2001-06-30 | $0.04B | $0.17B | 24.65% |
| 2001-03-31 | $0.04B | $0.16B | 19.37% |
| 2000-12-31 | $0.03B | $0.15B | 15.05% |
| 2000-09-30 | $0.01B | $0.23B | 5.61% |
| 2000-06-30 | $0.00B | $0.22B | 0.51% |
| 2000-03-31 | $0.00B | $0.22B | 2.01% |
| 1999-12-31 | $0.01B | $0.12B | 6.01% |
| 1999-09-30 | $0.03B | $0.23B | 13.18% |
| 1999-06-30 | $0.03B | $0.23B | 12.59% |
| 1999-03-31 | $0.03B | $0.22B | 12.40% |
| 1998-12-31 | $0.02B | $0.20B | 11.64% |
| 1998-09-30 | $0.02B | $0.21B | 9.52% |
| 1998-06-30 | $0.02B | $0.21B | 10.24% |
| 1998-03-31 | $0.02B | $0.21B | 9.41% |
| 1997-12-31 | $0.02B | $0.17B | 8.58% |
| 1997-09-30 | $0.02B | $0.20B | 9.46% |
| 1997-06-30 | $0.02B | $0.19B | 11.78% |
| 1997-03-31 | $0.03B | $0.19B | 13.76% |
| 1996-12-31 | $0.03B | $0.18B | 15.32% |
| 1996-09-30 | $0.03B | $0.18B | 17.70% |
| 1996-06-30 | $0.03B | $0.17B | 16.67% |
| 1996-03-31 | $0.03B | $0.17B | 16.75% |
| 1995-12-31 | $0.03B | $0.16B | 16.81% |
| 1995-09-30 | $0.02B | $0.15B | 16.20% |
| 1995-06-30 | $0.02B | $0.15B | 16.94% |
| 1995-03-31 | $0.02B | $0.14B | 14.70% |
| 1994-12-31 | $0.02B | $0.13B | 12.93% |
| 1994-09-30 | $0.01B | $0.13B | 9.26% |
| 1994-06-30 | $0.01B | $0.12B | 6.07% |
| 1994-03-31 | $0.00B | $0.12B | 3.55% |
| 1993-12-31 | $0.00B | $0.11B | 1.80% |
| 1993-09-30 | $0.00B | $0.11B | 3.63% |
| 1993-06-30 | $0.01B | $0.11B | 5.49% |
| 1993-03-31 | $0.01B | $0.11B | 12.99% |
| 1992-12-31 | $0.02B | $0.11B | 14.46% |
| 1992-09-30 | $0.02B | $0.11B | 15.04% |
| 1992-06-30 | $0.02B | $0.11B | 15.83% |
| 1992-03-31 | $0.01B | $0.10B | 8.89% |
| 1991-12-31 | $0.01B | $0.09B | 9.12% |
| 1991-09-30 | $0.01B | $0.09B | 11.73% |
| 1991-06-30 | $0.01B | $0.09B | 12.12% |
| 1991-03-31 | $0.01B | $0.09B | 13.71% |
| 1990-12-31 | $0.01B | $0.08B | 14.24% |
| 1990-09-30 | $0.01B | $0.08B | 13.47% |
| 1990-06-30 | $0.01B | $0.08B | 12.59% |
| 1990-03-31 | $0.01B | $0.07B | 14.65% |
| 1989-12-31 | $0.01B | $0.07B | 13.79% |
| 1989-09-30 | $0.01B | $0.07B | 14.29% |
| 1989-06-30 | $0.01B | $0.06B | 16.46% |
| 1989-03-31 | $0.01B | $0.06B | 17.02% |
| 1988-12-31 | $0.01B | $0.06B | 17.62% |
| 1988-09-30 | $0.01B | $0.06B | 18.43% |
| 1988-06-30 | $0.01B | $0.06B | 17.22% |
| 1988-03-31 | $0.01B | $0.05B | 15.92% |
| 1987-12-31 | $0.01B | $0.05B | 14.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $8.457B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $211.725B | 24.40 |
| EssilorLuxottica (ESLOY) | France | $146.103B | 0.00 |
| Stryker (SYK) | United States | $139.118B | 27.62 |
| Boston Scientific (BSX) | United States | $130.559B | 29.85 |
| Medtronic (MDT) | Ireland | $124.048B | 17.19 |
| Medline (MDLN) | United States | $57.961B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.907B | 0.00 |
| Agilent Technologies (A) | United States | $39.588B | 25.03 |
| ResMed (RMD) | United States | $37.591B | 26.02 |
| GE HealthCare Technologies (GEHC) | United States | $37.239B | 17.81 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $20.476B | 23.05 |
| Insulet (PODD) | United States | $20.239B | 62.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.303B | 10.79 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.893B | 0.00 |
| Baxter (BAX) | United States | $10.338B | 8.34 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.261B | 12.98 |
| Envista Holdings (NVST) | United States | $4.150B | 23.81 |
| BillionToOne (BLLN) | United States | $4.061B | 0.00 |
| ICU Medical (ICUI) | United States | $3.855B | 24.48 |
| Haemonetics (HAE) | United States | $3.378B | 15.04 |
| Prestige Consumer Healthcare (PBH) | United States | $3.131B | 14.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.255B | 14.50 |
| Perrigo (PRGO) | Ireland | $2.068B | 5.18 |
| Neogen (NEOG) | United States | $2.012B | 44.05 |
| LeMaitre Vascular (LMAT) | United States | $2.002B | 40.31 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.805B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 73.55 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.333B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 348.86 |
| Capricor Therapeutics (CAPR) | United States | $1.113B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.062B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.002B | 0.00 |
| InMode (INMD) | Israel | $0.881B | 9.96 |
| Valneva SE (VALN) | France | $0.867B | 0.00 |
| Omeros (OMER) | United States | $0.852B | 0.00 |
| CeriBell (CBLL) | United States | $0.814B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.67 |
| Cerus (CERS) | United States | $0.499B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.479B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| Evolus (EOLS) | United States | $0.337B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| TerrAscend (TSNDF) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.27 |
| Accendra Health (ACH) | United States | $0.195B | 1.95 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Exagen (XGN) | United States | $0.106B | 0.00 |
| Biote (BTMD) | United States | $0.106B | 4.64 |
| Sharps Technology (STSS) | United States | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 24.46 |
| Nephros (NEPH) | United States | $0.048B | 34.46 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.67 |
| Jin Medical (ZJYL) | China | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |